This inventor holds 1 USPTO granted patent. Top assignee: Shouyao Holdings (Beijing) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dechuang Yuan: Innovator in RET Selective Inhibitors
Introduction
Dechuang Yuan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors. His work focuses on innovative solutions for treating diseases related to RET.
Latest Patents
Dechuang Yuan holds a patent for an RET selective inhibitor, along with its preparation method and uses. The invention provides a compound of formula (1) and includes pharmaceutically accepted salts, solvates, polymorphs, or tautomers. This patent outlines the composition of these compounds and their application in treating diseases associated with RET. He has 1 patent to his name.
Career Highlights
Yuan is associated with Shouyao Holdings (Beijing) Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, contributing to innovative treatments that address critical health issues.
Collaborations
Some of his notable coworkers include Zhihua Liu and Kuncheng Chen. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Dechuang Yuan's contributions to the field of RET selective inhibitors exemplify his commitment to innovation in pharmaceuticals. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in the treatment of RET-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile